The United States Gastrointestinal (GI) Stent Market size is reached a valuation of USD xx.x Billion in 2023, with projections to achieve USD xx.x Billion by 2031, demonstrating a compound annual growth rate (CAGR) of xx.x% from 2024 to 2031.
United States Gastrointestinal (GI) Stent Market By Application
- Esophageal Stents
- Duodenal Stents
- Colonic Stents
- Biliary Stents
- Pancreatic Stents
The United States gastrointestinal (GI) stent market is segmented by application into several key areas. Esophageal stents are used primarily to treat narrowing or strictures in the esophagus, often caused by conditions such as esophageal cancer or benign strictures. Duodenal stents are designed to relieve obstructions in the duodenum, frequently caused by pancreatic cancer or other digestive tract tumors.
Colonic stents serve as a minimally invasive option for managing colorectal obstructions, offering palliative relief or as a bridge to surgery. Biliary stents are crucial in managing biliary strictures and blockages, typically arising from conditions like gallstones or pancreatic cancer. Pancreatic stents are used to manage strictures or leaks in the pancreatic duct, aiding in the drainage of pancreatic fluids and maintaining duct patency.